Rankings
▼
Calendar
BDSX (Biodesix, Inc.) Stock Financials & Earnings | Market Cap Arena
BDSX
Biodesix, Inc.
Mkt Cap
$151M
Healthcare
·
Medical - Diagnostics & Research
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$88M
Net Income (TTM)
-$35M
EPS (TTM)
-$4.85
Free Cash Flow (TTM)
-$24M
Gross Margin
81.1%
Op. Margin
-31.5%
Net Margin
-39.8%
FCF Margin
-26.7%
P/S Ratio (TTM)
1.7x
P/E Ratio (TTM)
—
YoY Rev Growth
+24.1%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$9M
$6M
-$16M
Q2 23
$12M
$9M
-$11M
Q3 23
$13M
$10M
-$7M
Q4 23
$15M
$11M
-$7M
Q1 24
$15M
$12M
-$11M
Q2 24
$18M
$14M
-$8M
Q3 24
$18M
$14M
-$9M
Q4 24
$20M
$16M
-$7M
Q1 25
$18M
$14M
-$9M
Q2 25
$20M
$16M
-$10M
Q3 25
$22M
$18M
-$7M
Q4 25
$29M
$24M
-$2M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
3.7x
—
Q2 23
3.6x
—
Q3 23
3.4x
—
Q4 23
3.1x
—
Q1 24
2.7x
—
Q2 24
2.5x
—
Q3 24
2.3x
—
Q4 24
2.1x
—
Q1 25
2.0x
—
Q2 25
2.0x
—
Q3 25
1.9x
—
Q4 25
1.7x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$8M
-$15M
Q2 23
$937K
-$6M
Q3 23
-$4M
-$10M
Q4 23
-$12M
-$15M
Q1 24
-$15M
-$16M
Q2 24
-$19M
-$21M
Q3 24
-$11M
-$11M
Q4 24
-$4M
-$5M
Q1 25
-$9M
-$9M
Q2 25
-$7M
-$7M
Q3 25
-$9M
-$9M
Q4 25
$778K
$629K
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$8M
Q2 23
$6M
Q3 23
$6M
Q4 23
$3M
Q1 24
$273K
Q2 24
$2M
Q3 24
$286K
Q4 24
$884K
Q1 25
$137K
Q2 25
$51K
Q3 25
$48K
Q4 25
$149K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+38.3%
+21.0%
Q2 23
+8.4%
+1.0%
Q3 23
+21.5%
-4.9%
Q4 23
+52.7%
-8.4%
Q1 24
+63.6%
+1.6%
Q2 24
+51.0%
+14.8%
Q3 24
+34.5%
+29.4%
Q4 24
+39.3%
+25.9%
Q1 25
+21.2%
+4.9%
Q2 25
+11.7%
+13.7%
Q3 25
+19.9%
+7.8%
Q4 25
+40.8%
+13.5%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$2M
25.2%
Q2 23
$1M
8.9%
Q3 23
$954K
7.1%
Q4 23
$1M
7.4%
Q1 24
$3M
17.8%
Q2 24
$1M
6.8%
Q3 24
$2M
8.3%
Q4 24
$1M
6.2%
Q1 25
$972K
5.4%
Q2 25
$1M
5.2%
Q3 25
$1M
4.8%
Q4 25
$1M
3.7%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
SG&A
Quarter
R&D
G&A
S&M
SG&A
Q1 23
$3M
—
$19M
—
Q2 23
$3M
—
—
$17M
Q3 23
$2M
—
—
$15M
Q4 23
$2M
$35M
—
—
Q1 24
$2M
—
—
$21M
Q2 24
$3M
—
—
$20M
Q3 24
$3M
—
—
$20M
Q4 24
$2M
—
—
$20M
Q1 25
$3M
—
—
$20M
Q2 25
$3M
—
—
$22M
Q3 25
$3M
—
—
$22M
Q4 25
$3M
—
—
$23M
marketcaparena.com
Revenue Segments
Diagnostic Tests
Service
Development Services
Quarter
Diagnostic Tests
Service
Development Services
Q1 23
$9M
$411K
—
Q2 23
$11M
$423K
—
Q3 23
$12M
$1M
—
Q1 25
$16M
—
$2M
Q2 25
$18M
—
$2M
Q3 25
$20M
—
$2M
Q4 25
$25M
—
$4M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$25M
$0
$25M
Q2 23
$17M
$0
$17M
Q3 23
$20M
$0
$20M
Q4 23
$26M
$0
$26M
Q1 24
$11M
$0
$11M
Q2 24
$42M
$0
$42M
Q3 24
$31M
$0
$31M
Q4 24
$26M
$0
$26M
Q1 25
$18M
$0
$18M
Q2 25
$21M
$0
$21M
Q3 25
$17M
$0
$17M
Q4 25
$19M
$0
$19M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
78M
+34.5%
Q2 23
79M
+1.0%
Q3 23
80M
+1.5%
Q4 23
5M
-94.2%
Q1 24
97M
+2004.9%
Q2 24
6M
-93.5%
Q3 24
7M
+15.0%
Q4 24
7M
+0.2%
Q1 25
7M
-0.0%
Q2 25
7M
+0.1%
Q3 25
8M
+2.3%
Q4 25
8M
+7.5%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 18
—
—
FY 19
—
—
FY 20
$228K
200
FY 21
$250K
218
FY 22
$156K
245
FY 23
$226K
217
FY 24
$261K
273
FY 25
$265K
334
marketcaparena.com